CompaniesMarker Gene Technologies

Marker Gene Technologies

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

106

By Phase

NA: 1EARLY_PHASE1: 1

By Status

COMPLETED: 1UNKNOWN: 1TERMINATED: 1

Recent Trials

NCT06415656Collaborator
VitalTraq for the Detection of CRS
NACompleted
32 participants
Started: Oct 13, 2024 · Completed: Jul 7, 2025
NCT03264833Collaborator
Accuracy and Precision Comparison of Temptraq
N/AUnknown
50 participants
Started: Dec 15, 2016 · Completed: Sep 1, 2017
NCT02237287Collaborator
Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers
EARLY_PHASE1Terminated
24 participants
Started: Feb 28, 2011 · Completed: Aug 31, 2012
Related Companies
Abcam
acquired